×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
UNCY – unicycive therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
UNCY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/30
08:42 am
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/29
04:27 pm
uncy
Unicycive resubmits NDA for hyperphosphatemia asset [Seeking Alpha]
Medium
Report
Unicycive resubmits NDA for hyperphosphatemia asset [Seeking Alpha]
12/29
07:47 am
uncy
Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth [Yahoo! Finance]
Medium
Report
Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth [Yahoo! Finance]
12/29
07:21 am
uncy
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
12/29
07:05 am
uncy
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
Medium
Report
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
12/10
11:42 am
uncy
2025 Forbes Healthcare Summit | How To Make Medicine Personal [Forbes]
Low
Report
2025 Forbes Healthcare Summit | How To Make Medicine Personal [Forbes]
11/25
01:58 pm
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/25
08:01 am
uncy
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
Low
Report
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/14
06:34 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Medium
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
11/14
05:10 pm
uncy
Form 8-K Unicycive Therapeutics, For: Nov 14
Medium
Report
Form 8-K Unicycive Therapeutics, For: Nov 14
11/14
05:09 pm
uncy
Form 424B5 Unicycive Therapeutics,
Medium
Report
Form 424B5 Unicycive Therapeutics,
11/14
04:53 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
11/14
04:46 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
11/14
04:26 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
03:02 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: GREAT POINT PARTNERS LLC
11/12
09:12 am
uncy
Form 8-K Unicycive Therapeutics, For: Nov 12
Medium
Report
Form 8-K Unicycive Therapeutics, For: Nov 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: